A photo of Vincent Mukkada.

Medical Director, Lumen Inpatient Unit

Medical Director, A4S

Associate Professor, UC Department of Pediatrics

513-636-4415

Board Certified

My Biography & Research

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Gastroenterology GI, Feeding and Swallowing Problems, Eosinophilic Disorders, Aerodigestive and Sleep, Aerodigestive and Esophageal, Eosinophilic Disorders

My Locations

My Education

BA: University of Pennsylvania, Philadelphia, PA, 1998.

MD: University of Cincinnati, Cincinnati, OH, 2002.

Residency: Pediatrics, Brown University / Hasbro Children’s Hospital, Providence, RI, 2002-2005.

Fellowship: Pediatric Gastroenterology, University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2005-2008.

Research Scholar: University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2008-2009.

Certifications: General Pediatrics, 2005; Pediatric Gastroenterology, 2009.

My Publications

17 beta-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling. Wheeler, JC; Vanoni, S; Zeng, C; Waggoner, L; Yang, Y; Wu, D; Uddin, J; Karns, R; Kottyan, L; Mukkada, V; et al. Journal of Allergy and Clinical Immunology. 2019; 143:2131-2146.

Prevalence of eosinophilic colitis and the diagnoses associated with colonic eosinophilia. DiTommaso, LA; Rosenberg, CE; Eby, MD; Tasco, A; Collins, MH; Lyles, JL; Putnam, PE; Mukkada, VA; Rothenberg, ME. Journal of Allergy and Clinical Immunology. 2019; 143:1928-1930.e3.

Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis. Wen, T; Aronow, BJ; Rochman, Y; Rochman, M; Kiran, KC; Dexheimer, PJ; Putnam, P; Mukkada, V; Foote, H; Rehn, K; et al. Journal of Clinical Investigation. 2019; 129:2014-2028.

Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Kottyan, LC; Maddox, A; Braxton, JR; Stucke, EM; Mukkada, V; Putnam, PE; Abonia, JP; Chehade, M; Wood, RA; Pesek, RD; et al. Genes and Immunity. 2019; 20:281-292.

Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis. Zeng, C; Vanoni, S; Wu, D; Caldwell, JM; Wheeler, JC; Arora, K; Noah, TK; Waggoner, L; Besse, JA; Yamani, AN; et al. Journal of Allergy and Clinical Immunology. 2018; 142:1843-1855.

The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease Reply. Mukkada, VA. Clinical Gastroenterology and Hepatology. 2018; 16:1841-1842.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Dellon, ES; Liacouras, CA; Molina-Infante, J; Furuta, GT; Spergel, JM; Zevit, N; Spechler, SJ; Attwood, SE; Straumann, A; Aceves, SS; et al. Gastroenterology. 2018; 155:1022-1033.e10.

Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis. Rosenberg, CE; Mingler, MK; Caldwell, JM; Collins, MH; Fulkerson, PC; Morris, DW; Mukkada, VA; Putnam, PE; Shoda, T; Wen, T; et al. Allergy: European Journal of Allergy and Clinical Immunology. 2018; 73:1892-1901.

Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?. Ferguson, AE; Mukkada, VA; Fulkerson, PC. Clinical Reviews in Allergy and Immunology. 2018; 55:43-55.

Eosinophilic Esophagitis: an Important Comorbid Condition of Asthma?. Durrani, SR; Mukkada, VA; Guilbert, TW. Clinical Reviews in Allergy and Immunology. 2018; 55:56-64.